Search research articles
Contact Us
Filters
Showing results (861-870 of 1,005) with videos related to
Page
of 101
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry
|
September 5, 2018
How common is truly benign MS in a UK population?
Emma Clare Tallantyre, Paula C Major, Michael J Atherton, et al.
American Journal of Medical Genetics. Part A
|
August 14, 2008
Spondyloepiphyseal dysplasia, Omani type: further definition of the phenotype
Mirjam H H van Roij, Shuji Mizumoto, Shuhei Yamada, et al.
The American Journal of Medicine
|
April 1, 1989
Comparison of enalapril and atenolol in mild to moderate hypertension
A L Herrick, P C Waller, K E Berkin, et al.
AJNR. American Journal of Neuroradiology
|
October 13, 2022
Distinctive Brain Malformations in Zhu-Tokita-Takenouchi-Kim Syndrome
B J Halliday, G Baynam, L Ewans, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
September 23, 2018
Assessing the long-term effectiveness of interferon-beta and glatiramer acetate in multiple sclerosis: final 10-year results from the UK multiple sclerosis risk-sharing scheme
Jacqueline Palace, Martin Duddy, Michael Lawton, et al.
Neurology
|
July 29, 2011
Autoimmune disease after alemtuzumab treatment for multiple sclerosis in a multicenter cohort
M Cossburn, A A Pace, J Jones, et al.
Nano Letters
|
April 16, 2009
Calcium phosphate nanocomposite particles for in vitro imaging and encapsulated chemotherapeutic drug delivery to cancer cells
Mark Kester, Yasser Heakal, Todd Fox, et al.
Journal of Neurology
|
January 6, 2010
Alemtuzumab in the treatment of IVIG-dependent chronic inflammatory demyelinating polyneuropathy
E A Marsh, C L Hirst, J G Llewelyn, et al.
Journal of Inherited Metabolic Disease
|
October 27, 2015
Brain dopamine-serotonin vesicular transport disease presenting as a severe infantile hypotonic parkinsonian disorder
Jessie C Jacobsen, Callum Wilson, Vicki Cunningham, et al.
Multiple Sclerosis and Related Disorders
|
September 11, 2022
Multiple sclerosis and COVID-19: Assessing risk perception, patient behaviors and access to disease-modifying therapies
R Beesley, M Cauchi, L Davies, et al.
Page
of 101
Search research articles
Search
Showing results (861-870 of 1,005) with videos related to
Sort By:
Page
of 101
Journal of Neurology, Neurosurgery, and Psychiatry
|
September 5, 2018
How common is truly benign MS in a UK population?
Emma Clare Tallantyre, Paula C Major, Michael J Atherton, et al.
American Journal of Medical Genetics. Part A
|
August 14, 2008
Spondyloepiphyseal dysplasia, Omani type: further definition of the phenotype
Mirjam H H van Roij, Shuji Mizumoto, Shuhei Yamada, et al.
The American Journal of Medicine
|
April 1, 1989
Comparison of enalapril and atenolol in mild to moderate hypertension
A L Herrick, P C Waller, K E Berkin, et al.
AJNR. American Journal of Neuroradiology
|
October 13, 2022
Distinctive Brain Malformations in Zhu-Tokita-Takenouchi-Kim Syndrome
B J Halliday, G Baynam, L Ewans, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
September 23, 2018
Assessing the long-term effectiveness of interferon-beta and glatiramer acetate in multiple sclerosis: final 10-year results from the UK multiple sclerosis risk-sharing scheme
Jacqueline Palace, Martin Duddy, Michael Lawton, et al.
Neurology
|
July 29, 2011
Autoimmune disease after alemtuzumab treatment for multiple sclerosis in a multicenter cohort
M Cossburn, A A Pace, J Jones, et al.
Nano Letters
|
April 16, 2009
Calcium phosphate nanocomposite particles for in vitro imaging and encapsulated chemotherapeutic drug delivery to cancer cells
Mark Kester, Yasser Heakal, Todd Fox, et al.
Journal of Neurology
|
January 6, 2010
Alemtuzumab in the treatment of IVIG-dependent chronic inflammatory demyelinating polyneuropathy
E A Marsh, C L Hirst, J G Llewelyn, et al.
Journal of Inherited Metabolic Disease
|
October 27, 2015
Brain dopamine-serotonin vesicular transport disease presenting as a severe infantile hypotonic parkinsonian disorder
Jessie C Jacobsen, Callum Wilson, Vicki Cunningham, et al.
Multiple Sclerosis and Related Disorders
|
September 11, 2022
Multiple sclerosis and COVID-19: Assessing risk perception, patient behaviors and access to disease-modifying therapies
R Beesley, M Cauchi, L Davies, et al.
Page
of 101